Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 First MAb approved for treatment of metastatic breast cancer.

× No keyword cloud information.

8 in total

Review 1. Nanomedicine therapeutic approaches to overcome cancer drug resistance.

Authors: Janet L Markman; Arthur Rekechenetskiy; Eggehard Holler; Julia Y Ljubimova
Journal: Adv Drug Deliv Rev Date: 2013-10-10 Impact factor: 15.470

2. Internalization, intracellular trafficking, and biodistribution of monoclonal antibody 806: a novel anti-epidermal growth factor receptor antibody.

Authors: Rushika M Perera; Roberto Zoncu; Terrance G Johns; Marc Pypaert; Fook-Thean Lee; Ira Mellman; Lloyd J Old; Derek K Toomre; Andrew M Scott
Journal: Neoplasia Date: 2007-12 Impact factor: 5.715

3. FT-IR microspectrometry reveals the variation of membrane polarizability due to epigenomic effect on epithelial ovarian cancer.

Authors: Morris M H Hsu; Pei-Yu Huang; Yao-Chang Lee; Yuang-Chuen Fang; Michael W Y Chan; Cheng-I Lee
Journal: Int J Mol Sci Date: 2014-10-08 Impact factor: 5.923

4. Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance.

Authors: Corinna Bingel; Emily Koeneke; Johannes Ridinger; Annika Bittmann; Martin Sill; Heike Peterziel; Jagoda K Wrobel; Inga Rettig; Till Milde; Uta Fernekorn; Frank Weise; Andreas Schober; Olaf Witt; Ina Oehme
Journal: Cell Death Dis Date: 2017-08-24 Impact factor: 8.469

Review 5. Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies.

Authors: Alex Françoso; Patricia Ucelli Simioni
Journal: Drug Des Devel Ther Date: 2017-01-11 Impact factor: 4.162

6. Efficacy and Safety of Anti-HER2 Agents in Combination With Chemotherapy for Metastatic HER2-Positive Breast Cancer Patient: A Network Meta-Analysis.

Authors: Xiaohui Zhang; Junsheng Leng; Yidong Zhou; Feng Mao; Yan Lin; Songjie Shen; Qiang Sun
Journal: Front Oncol Date: 2021-08-19 Impact factor: 6.244

7. Guideline concordant therapy prolongs survival in HER2-positive breast cancer patients: results from a large population-based cohort of a cancer registry.

Authors: E C Inwald; O Ortmann; F Zeman; M Koller; F Hofstädter; M Gerstenhauer; M Klinkhammer-Schalke
Journal: Biomed Res Int Date: 2014-03-20 Impact factor: 3.411

Review 8. Therapeutic applications of monoclonal antibodies.

Authors: Mitchell Berger; Vidya Shankar; Abbas Vafai
Journal: Am J Med Sci Date: 2002-07 Impact factor: 2.378

8 in total